Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Beryl Drugs Ltd (NSE: BERLDRG), ISIN INE415H01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BERLDRG last traded at ₹25.25 (-1.75%), with a 52-week range of ₹15.92 to ₹29.90 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 27.97%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 60/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.